Oxidative stress in Hashimoto's thyroiditis: possible adjuvant therapies to attenuate deleterious effects

Mol Cell Biochem. 2023 Apr;478(4):949-966. doi: 10.1007/s11010-022-04564-4. Epub 2022 Sep 27.

Abstract

A number of studies have shown that oxidative stress is related to the pathogenesis of several immunological diseases, such as Hashimoto's thyroiditis (HT), although there is no plausible mechanism to explain it. Thus, we aimed at hypothesizing and providing some possible mechanisms linking oxidative stress to autoimmunity aspects and its implications for HT, as well as adjuvant therapeutic proposals to mitigate the deleterious effects. Our hypothesis is that deficient eating habits, autoimmune regulator gene predisposing gene, dysbiosis and molecular mimicry, unfolded proteins and stress in the endoplasmic reticulum, and thymus involution appear to be the main potential factors leading to HT oxidative stress. Likewise, we show that the use of minerals selenium and zinc, vitamins D and C, as well as probiotics, can be interesting adjuvant therapies for the control of oxidative damage and poor prognosis of HT. Further clinical trials are needed to understand the real beneficial and side effects of these supplements.

Keywords: Antioxidant; Autoantibody; Autoimmune disease; Free radicals; Thyroid.

Publication types

  • Review

MeSH terms

  • Dietary Supplements
  • Hashimoto Disease* / pathology
  • Hashimoto Disease* / therapy
  • Humans
  • Oxidative Stress

Grants and funding